INVO Fertility, Inc. (IVF)

Every figure this model derived for IVF, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 43,412 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 1,962,159 CashAndCashEquivalentsAtCarryingValue 2022-06-30
current assets 4,602,765 AssetsCurrent 2026-06-30
current liabilities 6,519,724 LiabilitiesCurrent 2026-06-30
equity 16,491,578 StockholdersEquity 2026-06-30
interest expense 1,130,460 InterestExpenseNonoperating 2026-06-30
ocf -4,769,352 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 7,531,121 Revenues 2026-06-30
sbc 162,920 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up IVF on one particular measure came for.

RatioValue
cash operating margin-69.1
current ratio0.8
current ratio reported0.71
deferred revenue growth0.0
dilution pct4569.51
fcf margin-63.91
growth cv1.21
interest cover-5.24
operating margin-78.72
owner earnings margin-66.07
revenue growth13.76
revenue growth per share-97.56
roic-28.3
rule of 40-64.95
sbc pct revenue2.16

What to be careful about

What this model itself distrusts about IVF's figures. Written by the derivation as it ran, not added afterwards.